These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 36089211)
1. Translational pharmacokinetics of a novel bispecific antibody against Ebola virus (MBS77E) from animal to human by PBPK modeling & simulation. Zhang W; Xiang Y; Wang L; Wang F; Li G; Zhuang X Int J Pharm; 2022 Oct; 626():122160. PubMed ID: 36089211 [TBL] [Abstract][Full Text] [Related]
2. A translational platform PBPK model for antibody disposition in the brain. Chang HY; Wu S; Meno-Tetang G; Shah DK J Pharmacokinet Pharmacodyn; 2019 Aug; 46(4):319-338. PubMed ID: 31115858 [TBL] [Abstract][Full Text] [Related]
3. Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human. Shah DK; Betts AM J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):67-86. PubMed ID: 22143261 [TBL] [Abstract][Full Text] [Related]
4. Prediction of Human Distribution Volumes of Compounds in Various Elimination Phases Using Physiologically Based Pharmacokinetic Modeling and Experimental Pharmacokinetics in Animals. Shimizu H; Yoshida K; Nakada T; Kojima K; Ogasawara A; Nakamaru Y; Yamazaki H Drug Metab Dispos; 2019 Feb; 47(2):114-123. PubMed ID: 30420404 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis. Peters SA Clin Pharmacokinet; 2008; 47(4):261-75. PubMed ID: 18336055 [TBL] [Abstract][Full Text] [Related]
6. Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profiles. Peters SA Clin Pharmacokinet; 2008; 47(4):245-59. PubMed ID: 18336054 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Success of High-Throughput Physiologically Based Pharmacokinetic (HT-PBPK) Modeling Predictions to Inform Early Drug Discovery. Naga D; Parrott N; Ecker GF; Olivares-Morales A Mol Pharm; 2022 Jul; 19(7):2203-2216. PubMed ID: 35476457 [TBL] [Abstract][Full Text] [Related]
8. Assessment and Confirmation of Species Difference in Nonlinear Pharmacokinetics of Atipamezole with Physiologically Based Pharmacokinetic Modeling. Li Z; Gao Y; Yang C; Xiang Y; Zhang W; Zhang T; Su R; Lu C; Zhuang X Drug Metab Dispos; 2020 Jan; 48(1):41-51. PubMed ID: 31699808 [TBL] [Abstract][Full Text] [Related]
9. Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions. Xia B; Heimbach T; Lin TH; He H; Wang Y; Tan E Cancer Chemother Pharmacol; 2012 Jun; 69(6):1567-82. PubMed ID: 22526410 [TBL] [Abstract][Full Text] [Related]
10. Development of a Translational Physiologically Based Pharmacokinetic Model for Antibody-Drug Conjugates: a Case Study with T-DM1. Khot A; Tibbitts J; Rock D; Shah DK AAPS J; 2017 Nov; 19(6):1715-1734. PubMed ID: 28808917 [TBL] [Abstract][Full Text] [Related]
11. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Accurately Predicts the Better Bronchodilatory Effect of Inhaled Versus Oral Salbutamol Dosage Forms. Boger E; Fridén M J Aerosol Med Pulm Drug Deliv; 2019 Feb; 32(1):1-12. PubMed ID: 29878860 [TBL] [Abstract][Full Text] [Related]
12. Physiologically Based Pharmacokinetic Models Can Be Used to Predict the Unique Nonlinear Absorption Profiles of Vismodegib. Lin L; Wright MR; Hop CECA; Wong H Drug Metab Dispos; 2022 Sep; 50(9):1170-1181. PubMed ID: 35779865 [TBL] [Abstract][Full Text] [Related]
13. Development of a PBPK model for monoclonal antibodies and simulation of human and mice PBPK of a radiolabelled monoclonal antibody. Heiskanen T; Heiskanen T; Kairemo K Curr Pharm Des; 2009; 15(9):988-1007. PubMed ID: 19275663 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the whole body physiologically based pharmacokinetic (WB-PBPK) modeling of drugs. Munir A; Azam S; Fazal S; Bhatti AI J Theor Biol; 2018 Aug; 451():1-9. PubMed ID: 29704489 [TBL] [Abstract][Full Text] [Related]
15. A novel strategy for physiologically based predictions of human pharmacokinetics. Jones HM; Parrott N; Jorga K; Lavé T Clin Pharmacokinet; 2006; 45(5):511-42. PubMed ID: 16640456 [TBL] [Abstract][Full Text] [Related]
16. DallphinAtoM: Physiologically based pharmacokinetics software predicting human PK parameters based on physicochemical properties, in vitro and animal in vivo data. Choi S; Han S; Lee SJ; Lim B; Bae SH; Han S; Yim DS Comput Methods Programs Biomed; 2022 Apr; 216():106662. PubMed ID: 35151112 [TBL] [Abstract][Full Text] [Related]
17. Prediction of Human Pharmacokinetics of E0703, a Novel Radioprotective Agent, Using Physiologically Based Pharmacokinetic Modeling and an Interspecies Extrapolation Approach. Ge YX; Zhang Z; Yan JY; Ma ZC; Wang YG; Xiao CR; Zhuang XM; Gao Y Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474292 [TBL] [Abstract][Full Text] [Related]
18. PBPK model for antibody disposition in mouse brain: validation using large-pore microdialysis data. Wu S; Le Prieult F; Phipps CJ; Mezler M; Shah DK J Pharmacokinet Pharmacodyn; 2022 Dec; 49(6):579-592. PubMed ID: 36088452 [TBL] [Abstract][Full Text] [Related]
19. Modelling and PBPK simulation in drug discovery. Jones HM; Gardner IB; Watson KJ AAPS J; 2009 Mar; 11(1):155-66. PubMed ID: 19280352 [TBL] [Abstract][Full Text] [Related]
20. Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration-Mean Residence Time Methods: Mechanistic Understanding of its Pharmacokinetics. Song L; Zhang Y; Jiang J; Ren S; Chen L; Liu D; Chen X; Hu P Clin Pharmacokinet; 2018 Oct; 57(10):1307-1323. PubMed ID: 29626326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]